e-Drug3D

1384

ETIDOCAINE

DISCONTINUED


INN
ETIDOCAINE

cas 36637-18-0
CLASS

NERVOUS SYSTEM
ANESTHETIC

ROUTE (list)

INJECTION

ATC code

N01BB07
N01BB57

PK parameters

Target

TARGET SODIUM CHANNEL

DrugCentral

Sodium channel protein type 5 subunit alpha UNIPROT Q14524 SCN5A

Sodium channel protein type 2 subunit alpha UNIPROT Q99250 SCN2A

Download SDF file Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-

Formula:
C17H28N2O

Calculated chemical properties:

MW 276.41
NB_atoms 20
XLogP 3.75
PSA 30.764
NB_HD 1
NB_HA 3
fsp3 0.59
Lipinski(0=no;1=yes) 1

FDA
NDA 017751 (pdf not found) INN (ETIDOCAINE HYDROCHLORIDE) DURANEST (ASTRAZENECA) APPROVAL= AP YEAR= 1976 NEWMOLECULARENTITY DISCONTINUED
NDA 021384 (pdf not found) INN (EPINEPHRINE BITARTRATE ; ETIDOCAINE HYDROCHLORIDE) DURANEST (DENTSPLY PHARM) APPROVAL= AP YEAR= 1976 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL